Skip to main content
. 2022 Mar 2;30(Suppl 1):71–80. doi: 10.3233/THC-228007

Table 2.

Demographic, clinical and hormonal characteristic of the study population

Parameters Controls (n= 109) PCOS (n= 126) t P values
Age (years) 30.97 ± 5.45 28.61 ± 4.11 3.77 < 0.01
Weight (kg) 54.73 ± 7.05 59.34 ± 9.96 -4.13 0.01
BMI (kg/m2) 19.18 ± 6.22 23.50 ± 3.58 -6.39 0.06
FSH (mIU/ml) 4.70 ± 1.02 5.15 ± 1.65 -2.53 < 0.01
LH (mIU/ml) 3.83 ± 1.42 7.88 ± 4.61 -9.36 < 0.01
LH/FSH 0.85 ± 0.36 1.74 ± 1.94 -5.06 < 0.01
E2 (pmmol/L) 144.95 ± 47.40 167.39 ± 270.89 -0.91 0.36
PRL (mIU/L)   328.18 ± 114.29 339.54 ± 116.03 -0.76 0.45
T (nmol/L) 0.95 ± 0.50 2.38 ± 1.41 -10.60 < 0.01
HOMA_IR 1.60 ± 0.55 4.27 ± 2.37 -12.27 < 0.01